{"nct_id":"NCT00811733","title":"A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia","status":"COMPLETED","status_verified_date":"2015-03","start_date":"2009-03-01","start_date_type":null,"primary_completion_date":"2011-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2014-02-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}